Keyword Analysis & Research: jcog1510

jcog.jp

https://jcog.jp/document/1510.pdf

食道がんグループ. 日本医療研究開発機構委託研究開発費 革新的がん医療実用化研究事業 「切除不能局所進行食道癌に対する標準治療確立のための研究」 国立がん研究センター研究開発費2023-J-03 「成人固形がんに対する標準治療確立のための基盤研究」班. JCOG1510. 切除不能局所進行胸部食道扁平上皮癌に対 … See more

DA: 91 PA: 72 MOZ Rank: 15

oup.com

https://academic.oup.com/jjco/article/49/11/1055/5549797

WebAug 14, 2019 · Phase III study of tri-modality combination therapy with induction docetaxel plus cisplatin and 5-fluorouracil versus definitive chemoradiotherapy for locally advanced … Author: Mitsumi Terada, Hiroki Hara, Hiroyuki Daiko, Junki Mizusawa, Tomohiro Kadota, Keisuke Hori, Hirofumi... Publish Year: 2019

Author: Mitsumi Terada, Hiroki Hara, Hiroyuki Daiko, Junki Mizusawa, Tomohiro Kadota, Keisuke Hori, Hirofumi...

Publish Year: 2019

DA: 4 PA: 35 MOZ Rank: 85

nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817845/

WebDec 20, 2022 · A randomized controlled trial (JCOG1510) is now in progress to confirm the advantage of DCF ICT over conventional dCRT, regarding overall survival in …

DA: 91 PA: 72 MOZ Rank: 45

nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603460/

WebNov 11, 2021 · Another multicenter randomized controlled trial (JCOG1510) further confirmed that induction chemotherapy + surgery or induction chemotherapy + … Author: Mao-Hui Yan, Fang Liu, Bao-Lin Qu, Bo-Ning Cai, Wei Yu, Xiang-Kun Dai DOI: 10.4251/wjgo.v13.i11.1781 Publish Year: 2021 Published: 2021/11/11

Author: Mao-Hui Yan, Fang Liu, Bao-Lin Qu, Bo-Ning Cai, Wei Yu, Xiang-Kun Dai

DOI: 10.4251/wjgo.v13.i11.1781

Publish Year: 2021

Published: 2021/11/11

DA: 32 PA: 65 MOZ Rank: 98

annalsofoncology.org

https://www.annalsofoncology.org/article/S0923-7534(19)49240-5/fulltext

WebTRIANgLE study (JCOG1510): A phase III study of tri-modality combination therapy with induction docetaxel (DOC), cisplatin (CDDP), 5-fluorouracil (FU) (DCF) vs definitive … Author: H. Daiko, H. Hara, H. Ogawa, K. Hori, J. Mizusawa, S. Ozawa, M. Takagi, M. Tanaka, H. Baba, Y. Shira... Publish Year: 2018

Author: H. Daiko, H. Hara, H. Ogawa, K. Hori, J. Mizusawa, S. Ozawa, M. Takagi, M. Tanaka, H. Baba, Y. Shira...

Publish Year: 2018

DA: 68 PA: 42 MOZ Rank: 54

nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831898/

WebOct 19, 2022 · A phase 3 study of tri‐modality combination therapy with induction docetaxel plus cisplatin and 5‐fluorouracil versus definitive chemoradiotherapy (JCOG1510) is …

DA: 96 PA: 2 MOZ Rank: 31

nih.gov

https://pubmed.ncbi.nlm.nih.gov/31411696/

WebDec 18, 2019 · Phase III study of tri-modality combination therapy with induction docetaxel plus cisplatin and 5-fluorouracil versus definitive chemoradiotherapy for locally advanced …

DA: 61 PA: 20 MOZ Rank: 40

springer.com

https://link.springer.com/article/10.1245/s10434-019-07654-8

WebAug 2, 2019 · Based on the COSMOS trial, a prospective randomized controlled trial (JCOG1510) is underway, in which chemoselection with DCF-ICT followed by CS is …

DA: 24 PA: 94 MOZ Rank: 12

nih.gov

https://pubmed.ncbi.nlm.nih.gov/36612007/

WebDec 20, 2022 · The Japan Clinical Oncology Group (JCOG) has conducted a three-arm phase III randomized controlled trial (JCOG1510) to confirm the superiority of DCF …

DA: 72 PA: 48 MOZ Rank: 100